| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Bright Minds Biosciences Inc (CN: DRUG)
DRUG Technical Analysis
4
| As on 12th Aug 2025 DRUG STOCK Price closed @ 56.68 and we RECOMMEND Buy for LONG-TERM with Stoploss of 7.20 & Strong Buy for SHORT-TERM with Stoploss of 2.06 we also expect STOCK to react on Following IMPORTANT LEVELS. |
DRUGSTOCK Price
| Open | 56.55 | Change | Price | % |
| High | 56.86 | 1 Day | 3.11 | 5.81 |
| Low | 56.55 | 1 Week | 12.57 | 28.50 |
| Close | 56.68 | 1 Month | 16.90 | 42.48 |
| Volume | 402 | 1 Year | 54.96 | 3195.35 |
| 52 Week High 102.72 | 52 Week Low 1.30 | ||||
CN Canada Most Active Stocks
| BIGG | 0.22 | 15.79% |
| ACDC | 0.06 | 0.00% |
| FMAN | 0.55 | 7.84% |
| PLTH | 0.64 | 30.61% |
| TER | 2.80 | 5.66% |
| PHRM | 0.38 | -28.30% |
| TRUL | 10.37 | -3.98% |
| GSK | 0.54 | 20.00% |
| NTAR | 0.10 | 25.00% |
| VST | 0.46 | 21.05% |
CN Canada Top Gainers Stocks
CN Canada Top Losers Stocks
| DRUG Daily Charts |
DRUG Intraday Charts |
Whats New @ Bazaartrend |
DRUG Free Analysis |
|
|
DRUG Important Levels Intraday
| RESISTANCE | 57.28 |
| RESISTANCE | 57.09 |
| RESISTANCE | 56.97 |
| RESISTANCE | 56.85 |
| SUPPORT | 56.51 |
| SUPPORT | 56.39 |
| SUPPORT | 56.27 |
| SUPPORT | 56.08 |
DRUG Forecast August 2025
| 4th UP Forecast | 58.76 |
| 3rd UP Forecast | 58.09 |
| 2nd UP Forecast | 57.68 |
| 1st UP Forecast | 57.27 |
| 1st DOWN Forecast | 56.09 |
| 2nd DOWN Forecast | 55.68 |
| 3rd DOWN Forecast | 55.27 |
| 4th DOWN Forecast | 54.6 |
DRUG Weekly Forecast
| 4th UP Forecast | 56.74 |
| 3rd UP Forecast | 56.72 |
| 2nd UP Forecast | 56.71 |
| 1st UP Forecast | 56.70 |
| 1st DOWN Forecast | 56.66 |
| 2nd DOWN Forecast | 56.65 |
| 3rd DOWN Forecast | 56.64 |
| 4th DOWN Forecast | 56.62 |
DRUG Forecast2025
| 4th UP Forecast | 262.31 |
| 3rd UP Forecast | 196.36 |
| 2nd UP Forecast | 155.6 |
| 1st UP Forecast | 114.84 |
| 1st DOWN Forecast | -1.48 |
| 2nd DOWN Forecast | -42.24 |
| 3rd DOWN Forecast | -83 |
| 4th DOWN Forecast | -148.95 |
Bright Minds Biosciences Inc ( CN Canada Symbol : DRUG )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
DRUG Business Profile
Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. The company was incorporated in 2019 and is headquartered in Vancouver, Canada. Address: 1500 ? 1055 West Georgia Street, Vancouver, BC, Canada, V6E 4N7
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service